» Articles » PMID: 39021434

Survival Prediction Landscape: an In-depth Systematic Literature Review on Activities, Methods, Tools, Diseases, and Databases

Overview
Date 2024 Jul 18
PMID 39021434
Authors
Affiliations
Soon will be listed here.
Abstract

Survival prediction integrates patient-specific molecular information and clinical signatures to forecast the anticipated time of an event, such as recurrence, death, or disease progression. Survival prediction proves valuable in guiding treatment decisions, optimizing resource allocation, and interventions of precision medicine. The wide range of diseases, the existence of various variants within the same disease, and the reliance on available data necessitate disease-specific computational survival predictors. The widespread adoption of artificial intelligence (AI) methods in crafting survival predictors has undoubtedly revolutionized this field. However, the ever-increasing demand for more sophisticated and effective prediction models necessitates the continued creation of innovative advancements. To catalyze these advancements, it is crucial to bring existing survival predictors knowledge and insights into a centralized platform. The paper in hand thoroughly examines 23 existing review studies and provides a concise overview of their scope and limitations. Focusing on a comprehensive set of 90 most recent survival predictors across 44 diverse diseases, it delves into insights of diverse types of methods that are used in the development of disease-specific predictors. This exhaustive analysis encompasses the utilized data modalities along with a detailed analysis of subsets of clinical features, feature engineering methods, and the specific statistical, machine or deep learning approaches that have been employed. It also provides insights about survival prediction data sources, open-source predictors, and survival prediction frameworks.

Citing Articles

RNA sequence analysis landscape: A comprehensive review of task types, databases, datasets, word embedding methods, and language models.

Asim M, Ibrahim M, Asif T, Dengel A Heliyon. 2025; 11(2):e41488.

PMID: 39897847 PMC: 11783440. DOI: 10.1016/j.heliyon.2024.e41488.

References
1.
Wang X, Chen J, Lin L, Li Y, Tao Q, Lang Z . Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma. BMC Cancer. 2023; 23(1):284. PMC: 10053113. DOI: 10.1186/s12885-023-10766-w. View

2.
Billheimer D, Gerner E, McLaren C, LaFleur B . Combined benefit of prediction and treatment: a criterion for evaluating clinical prediction models. Cancer Inform. 2014; 13(Suppl 2):93-103. PMC: 4197927. DOI: 10.4137/CIN.S13780. View

3.
Gerds T, Schumacher M . Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J. 2007; 48(6):1029-40. DOI: 10.1002/bimj.200610301. View

4.
Feng Y, Leung A, Lu X, Liang Z, Quan H, Walker R . Personalized prediction of incident hospitalization for cardiovascular disease in patients with hypertension using machine learning. BMC Med Res Methodol. 2022; 22(1):325. PMC: 9758895. DOI: 10.1186/s12874-022-01814-3. View

5.
Zhao Y, Wong L, Goh W . How to do quantile normalization correctly for gene expression data analyses. Sci Rep. 2020; 10(1):15534. PMC: 7511327. DOI: 10.1038/s41598-020-72664-6. View